Logo-brb

Biomedical Research Bulletin

Biomed Res Bull. 2024;2(1): 37-44.
doi: 10.34172/biomedrb.2024.06
  Abstract View: 58
  PDF Download: 77

Review Article

Stem Cells and Exosomes in Myocardial Ischemia-Reperfusion Injury: A Comprehensive Review of the Literature

Nasrin Abolhasanpour 1 ORCID logo, Fatemehsadat Syedaghamiri 2, Mojgan Rajabi 3,4, Mojtaba Ziaee 5, Leila Hosseini 6* ORCID logo

1 Research Center for Evidence-Based Medicine, Iranian EBM Centre: A Joanna Briggs Institute (JBI) Center of Excellence, Tabriz University of Medical Sciences, Tabriz, Iran
2 Department of Neuroscience, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
3 Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran
4 Department of Physiology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
5 Medical Plants Research Center, Maragheh University of Medical Science, Maragheh, Iran
6 Research Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
*Corresponding Author: Leila Hosseini, Email: leilahosseini337@gmail.com

Abstract

Ischemia-reperfusion injury (IRI) remains a global public health problem, with increasing incidence which is associated with significant morbidity and mortality. The duration of blood flow deprivation is a critical risk factor in conditions such as myocardial infarction (MI), stroke, solid organ transplantation, and hemorrhagic shock. From a pathophysiological perspective, IRI leads to numerous architectural, cellular, and metabolic changes in tissues. Moreover, local and systemic inflammation occurs after reperfusion of ischemic tissue. Clinically, the treatment of cases with IRI is frequently restricted to supportive maneuvers, with no exact target-oriented therapies validated so far. Recent research reveals the efficacy of stem cells as a promising therapeutic approach. Additionally, exosomes have been suggested to exert a significant impact on the stimulation of useful signaling pathways in different cardiovascular diseases. This review provided an overview of the new treatment strategies such as stem cell therapy (SCT) and exosome-based treatments for improving myocardial IRI.
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 59

Your browser does not support the canvas element.


PDF Download: 77

Your browser does not support the canvas element.

Submitted: 08 Mar 2023
Accepted: 18 Mar 2023
ePublished: 29 Mar 2024
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)